OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy
Rajagopalaboopathi Jayasudha, Taraprasad Das, Sama Kalyana Chakravarthy, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243077-e0243077
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Gut Microbiota and Complications of Type-2 Diabetes
Camelia Oana Iatcu, Aimee Steen, Mihai Covașă
Nutrients (2021) Vol. 14, Iss. 1, pp. 166-166
Open Access | Times Cited: 268

The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly
Fen Zhang, Dominik Aschenbrenner, Ji Youn Yoo, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e969-e983
Closed Access | Times Cited: 225

Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Zheng Zhou, Bao Sun, Dongsheng Yu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 195

Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
Yinhua Huang, Zhijie Wang, Hongjie Ma, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 123

A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseases
Qiulong Yan, Shenghui Li, Qingsong Yan, et al.
Cell (2024) Vol. 187, Iss. 12, pp. 2969-2989.e24
Closed Access | Times Cited: 36

Diabetes and gut microbiome
K. Fliegerová, Tiziana Maria Mahayri, Hana Sechovcová, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access | Times Cited: 3

The role of gut mycobiome in health and diseases
Lin Zhang, Hui Zhan, Wenye Xu, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 75

The Human Mycobiome: Colonization, Composition and the Role in Health and Disease
Paulína Belvončíková, Petra Šplíchalová, Petra Vídeňská, et al.
Journal of Fungi (2022) Vol. 8, Iss. 10, pp. 1046-1046
Open Access | Times Cited: 62

Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
Ahmad Al Samarraie, Maxime Pichette, Guy Rousseau
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5420-5420
Open Access | Times Cited: 40

Enterotypes of the human gut mycobiome
Senying Lai, Yan Yan, Yanni Pu, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 38

The leaky gut and the gut microbiome in sepsis – targets in research and treatment
Wiwat Chancharoenthana, Supitcha Kamolratanakul, Marcus J. Schultz, et al.
Clinical Science (2023) Vol. 137, Iss. 8, pp. 645-662
Open Access | Times Cited: 34

Gut mycobiome and metabolic diseases: The known, the unknown, and the future
Lijie Wang, Kun Zhang, Yujiao Zeng, et al.
Pharmacological Research (2023) Vol. 193, pp. 106807-106807
Open Access | Times Cited: 28

The Gut Mycobiome for Precision Medicine
Islam El Jaddaoui, Sofia Sehli, Najib Al Idrissi, et al.
Journal of Fungi (2025) Vol. 11, Iss. 4, pp. 279-279
Open Access | Times Cited: 1

Fecal Fungal Dysbiosis in Chinese Patients With Alzheimer’s Disease
Zongxin Ling, Manlian Zhu, Xia Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 45

Gut Microbiota Composition and Fecal Metabolic Profiling in Patients With Diabetic Retinopathy
Zixi Zhou, Zheng Zheng, Xiaojing Xiong, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 43

Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies
Yue Cai, Yongbo Kang
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114994-114994
Open Access | Times Cited: 20

Fungal infections and the fungal microbiome in hepatobiliary disorders
Phillipp Hartmann, Bernd Schnabl
Journal of Hepatology (2022) Vol. 78, Iss. 4, pp. 836-851
Open Access | Times Cited: 25

The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy
Haiyan Zhang, Ya Mo
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15

Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review
Aref Yarahmadi, Hamed Afkhami, Ali Javadi, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6

Ascomycetes yeasts: The hidden part of human microbiome
Stefano Nenciarini, Sonia Renzi, Monica Di Paola, et al.
WIREs Mechanisms of Disease (2024) Vol. 16, Iss. 3
Open Access | Times Cited: 5

The Role of Yeasts in Human Health: A Review
Cátia Filipa Caetano, Carlos Gaspar, José Martinez‐de‐Oliveira, et al.
Life (2023) Vol. 13, Iss. 4, pp. 924-924
Open Access | Times Cited: 13

Gut microbiome in diabetic retinopathy: A systematic review and meta-analysis
Shuang Zhao, Qi Yan, Wanjing Xu, et al.
Microbial Pathogenesis (2024) Vol. 189, pp. 106590-106590
Closed Access | Times Cited: 4

Postbiotics: emerging therapeutic approach in diabetic retinopathy
Qin Chen, Xuejian Li, Wei Xie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4

Analysis of the Gut Mycobiome in Adult Patients with Type 1 and Type 2 Diabetes Using Next-Generation Sequencing (NGS) with Increased Sensitivity—Pilot Study
Dominika Salamon, Agnieszka Sroka-Oleksiak, Artur Gurgul, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1066-1066
Open Access | Times Cited: 24

Page 1 - Next Page

Scroll to top